chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Report A0370902A describes the occurrence of a seizure in a 39 year old male who received hep A vaccine inactivated. The reporter submitted this report directly to VAERS. Medical history included a seizure disorder for twenty years, and concurrent medications included unspecified anti-seizure medications. It was also noted that the vaccinee received unspecified medication (dates unk) which are known to reduce the seizure threshold. On 5/29/02, the vaccinee received his first injection of Havrix. On that same day, he experienced a seizure witnessed by a friend. The seizure was preceded by the aura of arm numbness. The seizure was characterized by clonic movements limited to the arms, face and head. He was not incontinent. The vaccinee did not lose consciousness and was able to recall the event. There was no evidence that the seizure may have resulted from withdrawal of alcohol or other psychotropic substances, nor was there any evidence of a new neurological lesion or infection that might have been the cause of the seizure. Concentrations of unspecified serum electrolytes were found to be abnormal. Blood concentrations of his seizure medications were found to be in the "normal to high range." The seizure resolved that day. The reporter considered the seizure to be possibly related to Havrix administration. The Havrix immunization series was discontinued. Seizure is considered medically serious (OMIC).
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 68-year-old female patient who received SHINGRIX (batch number MY2B2, expiry date 22nd February 2021) for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 61 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional reported that the patient developed shingles approximately 2 months after receiving SHINGRIX. The reporter consented to follow up and the healthcare professional was unsure about the exact time the patient developed shingles, but approximately 2 months after the 1st dose.
patient reported swelling of the left side of the face 1.5-2 days after receiving the second Moderna vaccine which was administered on 3/13/2021.   The swelling started after he got injection of Eylea to the eye from his ophthalmologist on 3/15/2021.
Injection site progressively getting redder more firm to touch and pt. feels poorly. Sx: tired, queasy but nl appetite, no fever but clammy.
Typical symptoms following shot: sore, swollen arm with rash. Fever. Body aches. Chills. Headache. Nausea. Lasted for 48 hours. (Arm symptoms lasted closer to a week)  Beginning a week to two weeks later began to feel extreme fatigue, some nausea and dizziness. These are still in place. About a month after vaccine started feeling heart palpitations. Have a heart condition but have never experienced this.
On the day after the booster vaccination 01/22/2022 I had a temperature of 102F.  I then felt ok the following day 01/23/2022.  On Monday, 01/24/2022, around mid day I started to notice a degradation in my eye sight and chalked it up to the possible need for new glasses.  By the weekend of 01/29-30/2022, the degradation was bothering me enough to try my own test where I covered one eye and then the other.  At that time I determined that I was having a very difficult time seeing out of my left eye.  On 02/02/2022, I contact my Optometrist who referred me to an Opthalmologist.  The Opthalmologist advised me that I had extreme inflammation of the Optic Nerve in my left eye and that I should go directly to the ER at Eye Institute which I did.  I was diagnosed with Optic Neuritis in my left eye and was treated with Intravenous Steroids on 02/03/2022, 02/04/2022, and 02/05/2022.  I then went on a course of Prednisone tablets for 16 days ending yesterday, 02/21/2022.  I have a follow up appointment with Dr. this coming Friday, 02/25/2022.
Realized after patient left facility that she was given high dose. Patient is 1 month away from being 65. Vaers report filled out. Patient notified.
Sore at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at the injection site.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore at the injection site.). At the time of the report, VACCINATION SITE PAIN (Sore at the injection site.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Left arm extremely sore. Friday body aches, fever, severe chills, severe HA. Urgent Care Friday. IV fluids. Cannot lift left arm. Woke up Saturday (11-9-13) large rash on left arm, swollen and warm to the touch. Dr started Cefdinir on 11-9-13.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 17-JUN-2013 the patient was vaccinated with an expired dose of ZOSTAVAX, (dose, route and site of administration were not reported; lot number 672428/1599AA, expiration date:). No adverse effect was reported. Additional information has been requested.
Hospitalization for hyponatremia, COVID positive on dates 7/10/22-7/20/22. Treated with no covid-related medications.
Pt mother stated that the day after vaccines placement, she notice her daughter's upper right arm was, red and swollen, pt stated it hurt when she touches.
This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. The patient's pertinent medical history, drug reactions and allergies were not reported. Concomitant therapies were not provided. On an unknown date, the patient was at the pharmacy to complete her CERVARIX (dose, anatomical location lot# and expiration date were not reported) dosing series by using GARDASIL 9 intramuscular for prophylaxis (dose, anatomical location lot# and expiration date were not reported).
Redness and swelling at injection site on left arm. Feels hot to touch and is painful. Ice was applied to ice and patient was adviced to use Motrin and / or Benadryl as needed.
1hr p/vax mom gave pt bottle, mom noticed tremors 9shaking) in arms when pt reached for bottle lasted 3min;no other tremors noted;no loss of consciousness;did not go to ER or pediatrician;
Mom states - pt unable to walk - just not herself. Pt did walk into room and out of office - she was not running and jumping - seemed tired - Mom not happy with the way I gave shots. I wrote incorrect lot # down on form when checked out. I rewrote correct lot #.
Extreme pain and redness around injection site--could not raise arm without pain or lay on it.  Area of redness approx 3"X2".
Pt developed papules throughout his body except for his palms & soles of his feet. Vesicles had erythema surrounding sites. Lesions were pruritic. Multiple stages concentrated on his chest. TX w/ Valtrex. Consulted EPMU-2 Threat Assessment due to his recent immunization with varicella vaccine.
Tingling across shoulders and down spine that lasted about an hour. Dizziness that began the night of the injection and continued the next day.
Vaccine was initially stored in fridge on 14-Dec-2022 and administered on 19-Jan-2023; No adverse event; Patient received doses of the Moderna COVID19 vaccine bivalent after its beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received doses of the Moderna COVID19 vaccine bivalent after its beyond use date), PRODUCT STORAGE ERROR (Vaccine was initially stored in fridge on 14-Dec-2022 and administered on 19-Jan-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 19-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received doses of the Moderna COVID19 vaccine bivalent after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in fridge on 14-Dec-2022 and administered on 19-Jan-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received doses of the Moderna COVID19 vaccine bivalent after its beyond use date), PRODUCT STORAGE ERROR (Vaccine was initially stored in fridge on 14-Dec-2022 and administered on 19-Jan-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received doses of the Moderna COVID19 vaccine bivalent after its beyond use date) and PRODUCT STORAGE ERROR (Vaccine was initially stored in fridge on 14-Dec-2022 and administered on 19-Jan-2023).    No concomitant medication was provided.  Reportedly, total 9 patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date with lot number AS7168B. Vial size was 2.5mL and the date vial was initially stored in the fridge on 14 Dec 2022.   It was reported that vaccine was administered on different dates. One dose was given on the 13-Jan-2023, 4 doses were given on 14-Jan-2023 one dose was given on 16-Jan-2023, one dose was given on 17-Jan-2023 and two doses were given on 19-Jan-2023.  Vial did not undergone any temperature excursions.   Treatment medication was not provided by the reporter.  This case contains the information of 9th patient out of 9 patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-704964 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704964:Master case - 1st adult patient (vaccine start date: 13-Jan-2023)
Patient received one dose of the adult bivalent vaccine instead of the first dose of pediatric pfizer vaccine. No syptoms or issued reported.
04/06/2021 Hives - right leg -  06/08/2021 Hives - left leg - Symptoms, itching, spreading of hives from buttocks to knee back and side of leg (not front) Treatment both times: Dr. visit for inspection, xyzel, benedryl spray, liquid benedryl at night, cool compresses, anti itch cream, steroids prescribed second time, accupuncture visit for second time.  Have recovered each time, but unsure if it will be a chronic condition needing further and more extensive treatment.
Severe right lower abdominal pain 2 weeks after vaccination numbness in feet then hands then weakness - diagnosed with Guillain Barre 6/12 treated with immunoglobulin - better not at baseline.
11/07/21 my lower left calf started hurting, and on 11/08/21 that morning the pain was a 10 on a scale of 1-10. That afternoon I went to urgent care and they scheduled me for an ultrasound on 11/09 at 2:20PM and they called me around 5/6 PM and said I had two blood clots in my left lower leg. They started me on Xarelto 15 mg twice a day for weeks and I saw Dr. on 11/11/21 for a follow up and medication was reduced to 20 mg once a day and I'm still taking that and I would say the pain went away after a week. I go back to see Doctor on 02/28/22. I got the booster shot on 11/05, but my wife and I were driving back from a visit-- we left there 10/31/21 and got back home 11/04/21, so my legs were immobilized and the next day I got the booster. I've never had blood clots in the past, and my Doctor thinks it's a combination of the driving for 4-5 days and then getting the booster. I think if I waited to get boosted it wouldn't have happened.
On October 8, 2008 my family (husband, 2 sons, and myself) met at the middle school where our sons attend school, to receive our yearly flu shots. This is where the Department of Health was set up. The Flu shot that was given was administered very high in my left arm, in shoulder area. This shot hurt more than any other shot that I have received. I told the nurse that gave me the shot that it hurt extremely bad. She told me that the new syringes that they use now require them to put a little pressure on them to make the needle retract. After I was given the shot my arm started getting sore. In the next few weeks the pain increased, hurting when I tried to lift my arm, when I was laying down and rolled over on my left shoulder or when I was dressing or undressing. On October 21, 2008 I went to se my family doctor. He examined me and told me that the shot had either punctured the bursa sack in my left shoulder or had come extremely close to it, causing there to be some inflammation in that area. He prescribed me an anti- inflammatory medication, but that did not help the pain. On October 30, 2008 I went back to Dr, he then prescribed PREDNISONE. After taking this medication for 10 days, there was still no relief from the pain. On November 12, 2008 I went to see Dr, an orthopedic doctor. After his exam, he agreed with family Dr. diagnosis that the bursa area was inflamed due to shot. He gave me cortisone shot in my left shoulder to target the affected area, but still did not relieve pain. On December 2, 2008 I went back to Dr for 3 week follow- up. Since the cortisone shot did not help, Dr ordered an MRI. He said , depending on the results from the MRI, he may recommend physical therapy. On December 4, 2008 I went for MRI and currently have an appointment with Dr on December 9, 2008 to get results.
First night following after vaccine I woke up with chest pain ( i though pleuritic) which went away.  I had mild body aches and fatigue, chills. next day I experienced chest( again I thought pleuritic ) discomfort especially when taking a deep breath.  i felt better then had mild fatigue and body aches again.  day 3 post vaccine I woke up with discomfort when taking a deep breath with continued discomfort.  i felt tired through the day. Then that evening i developed SOB, severe palpitations  and chest pain and went to ER.  Diagnosis New onset rapid A fib.  I was hospitalized and once my work up was finished and I had normal sinus rhythm I was discharged home the next evening.
fever; chills; body aches; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 2 via an unspecified route of administration on 17Feb2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date the patient experienced fever, chills, body aches. The outcome of events was recovered.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
subjective fever & diffuse salmon colored macular rash over face, trunk, extremities 13 days p/vax;
Pain at site of vaccination, malaise continuing into 11/12. First time I received higher dosage vaccine for 65 and over.
patient was given a moderna shot 24 hours after it was opened; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was given a moderna shot 24 hours after it was opened) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was given a moderna shot 24 hours after it was opened). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was given a moderna shot 24 hours after it was opened) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided.   This case was linked to MOD-2021-347918 (Patient Link).   Reporter did not allow further contact
At time of injection,  dizziness,  pain at injection site,  pain in right arm fingers,  inability to grip with fingers on right arm.  Next day swelling of hands and feet.  Veins large and visible thru skin more than usual.  Continued dizziness.  Tylenol taken to deal with pain.   7 days later still minor dizziness.  Swelling of feet and hands continues.  Pain in right arm.  Pain in right hand and unable to grip with right hand.
arm was not usable/could not pick anything up/couldn't pick up milk in her fridge/couldn't pick up one pound; This spontaneous case was reported by a patient and describes the occurrence of LIMB DISCOMFORT (arm was not usable/could not pick anything up/couldn't pick up milk in her fridge/couldn't pick up one pound) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Patient had no allergies and patient not had COVID positive test or diagnosis. Patient not had any medical history. No any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced LIMB DISCOMFORT (arm was not usable/could not pick anything up/couldn't pick up milk in her fridge/couldn't pick up one pound). The patient was treated with Physical therapy for Limb discomfort. At the time of the report, LIMB DISCOMFORT (arm was not usable/could not pick anything up/couldn't pick up milk in her fridge/couldn't pick up one pound) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient reported that after the first vaccination arm was not usable and could not pick up anything. Prior to the first moderna vaccine patient was able to pick up 130 pounds in terms of pressing weight and patient hobby was weight lifting. After the vaccine patient could not pick up anything for close to 6 months. Patient stated that the vaccine was on bicep on left arm, patient works out and was very fit. Patient had Electromyogram(EMG). As a treatment patient was taking acupuncture and aquatic therapy. It was reported that there was some residual effects and the symptoms was improved but not 100 percent. Patient had not experienced similar events in past.   This case was linked to MOD-2022-644427 (Patient Link).
Dizzy, lightheaded, tingling right hand, (non-injection side),  cold feeling shooting down left arm (injection arm).  Evaluated by EMS- at 12:09 pm.  BP 132/84.   12:17pm dizziness resolving.  12:30 pm client feeling much better and discharged home.
Red, hot raised center in annular macule 6cm diameter of induration - itching.
This case was reported by a healthcare professional and described the occurrence of shortness of breath in a 73 year old subject of unspecified gender who was vaccinated with Flulaval for prophylaxis. Concurrent medications were not specified. On an unspecified date (15 November 2007 or later) the subject received 1st dose of Flulaval (unknown) with expiration date March 2008. In November 2007, at an unspecified time after vaccination with Flulaval, the subject experienced shortness of breath, fever, weakness and vomiting. The reaction was classified as systemic. The healthcare professional considered the events were disabling. The reporter suspected a safety and quality issue (product complaint) with the vaccine. At the time of reporting the outcome of the events was unspecified. It was indicated that these events occurred with multiple subjects. Nine specified at the time of the report. It was noted that 2 or 3 subjects had to be treated in the emergency room for these events. Most of the subjects recovered from the events after 2 to 4 days. Some subjects had not yet recovered at the time of reporting. Specifics on each individual subject were not provided.
Nausea, vomiting, severe  fatigue, body aches and pains, low grade fever ,chills
This case was reported by a nurse via sales rep and described the occurrence of adverse event in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.  It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The Field representative called to report adverse events that three different patients experienced on SHINGRIX as reported to her by the nurse. As per the field representative one of the the patient's husband went in to get the SHINGRIX and experienced some side effects with the SHINGRIX vaccine. No further details were provided as far as what kind of adverse event the patient experienced. The field representative had very limited information. Attempted to call nurse twice to get further information on the events but was not able to reach her. She also stated that nurse had reported the event to VAERS. This was 1 of 3 cases, reported by the same reporter.
Woke up middle of the night thinking I was having a heart attack; lasted 30-40 minutes Left side so painful couldn't lay on that side Often thru the night and next day felt as if I had the flu; cold and shivering one minute, sweating the next. Didn't sleep well at all that night and could not get myself out to take on the day as I usually do. Felt really tired and weak most of the day.
Narrative: Patient presented to ER on 12/1/21 with SOB over the past 2 days and concerns for low O2 sats. Used home nasal cannula on occasion. PMH includes COPD GOLD C, T2DM with neuropathy, alcohol/HCV cirrhosis and HTN. Reported occasional left-sided chest pain, typically when coughing (dry cough). Noted to be hypoxic in ER and immediately placed on 2L of nosal cannula, which improved O2 sats. Elevated troponins. COVID-19 and RSV positive. Dx with COVID-19 pneumonia, type 2 myocardial infarction (demand ischemia) due to COVID infection, and pulmonary infiltrate/pleural effusion which may be due to COVID 19 or cirrhosis. Treated with dexamethasone (12/1-12/4). Patient left AMA on 12/4/21 Discharged on dexamethasone taper for 6 days and supportive care medications.